AdaptHealth Corp.: Slimming Down Following The Sale Of The Diabetes Business
Jefferies Upgrades AdaptHealth to Buy, Raises Price Target to $13
AdaptHealth Corp. Announces Second Quarter 2026 Earnings Release Date and Conference Call
AdaptHealth discloses patient data was stolen in cyberattack
AdaptHealth discloses June cyberattack resulting in patient data exposure
Baird Maintains Outperform on AdaptHealth, Lowers Price Target to $15
AdaptHealth Discloses Investigation Into Security Incident Where Threat Actor Gained Authorized Access To Systems And Exfiltrated Certain Data; Determined Incident Is Material Due To Nature And Potential Volume; No Material Impact On Operations
AdaptHealth (AHCO) Stock Trades Up, Here Is Why
3 Reasons to Avoid AHCO and 1 Stock to Buy Instead
AdaptHealth (AHCO) Valuation Check As Shares Sit Below Popular US$18 Fair Value Narrative
The Top 5 Analyst Questions From AdaptHealth’s Q1 Earnings Call
Canaccord Lifts PT on AdaptHealth Corp. (AHCO) Following Q1 Results
AdaptHealth Conference: Kaiser Deal Drives Growth, Labor Costs Dent EBITDA
AdaptHealth Corp. (AHCO) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Senior Health, Home Health & Hospice Stocks Q1 Highlights: AdaptHealth (NASDAQ:AHCO)
AdaptHealth's Labor Headwinds Lead to Fast Onboarding of Capitated Contract, RBC Says
RBC Capital Maintains Outperform on AdaptHealth, Raises Price Target to $15
A Look At AdaptHealth (AHCO) Valuation As Investor Interest And Price Targets Diverge
AdaptHealth Corp. 2026 Q1 - Results - Earnings Call Presentation
Canaccord Genuity Maintains Buy on AdaptHealth, Raises Price Target to $16
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.